Sign Up Today and Learn More About Kinoxis Therapeutics Stock
Invest in or calculate the value of your shares in Kinoxis Therapeutics or other pre-IPO companies through EquityZen's platform.
Kinoxis Therapeutics Stock (KITH)
Kinoxis Therapeutics is a biotechnology company that develops a range of novel therapeutic compounds.
About Kinoxis Therapeutics Stock
Founded
2017
Industries
Software, Artificial Intelligence, Data and Analytics
Kinoxis Therapeutics Press Mentions
Stay in the know about the latest news on Kinoxis Therapeutics
Methods of treatment.
patents • May 04, 2025
Salts and crystals
patents • May 04, 2025
Oxytocin receptor modulators
patents • Apr 02, 2025
Therapeutic compounds and compositions for treating social disorders and …
patents • Feb 11, 2025
Methods of treatment
patents • Feb 11, 2025
Kinoxis Therapeutics Management
Leadership team at Kinoxis Therapeutics
Chief Scientific Officer, Co-Founder
Michael Bowen
Board
Peter Devine
Join now and verify your accreditation status to gain access to:
- Kinoxis Therapeutics Current Valuation
- Kinoxis Therapeutics Stock Price
- Kinoxis Therapeutics Management
- Available deals in Kinoxis Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Kinoxis Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Kinoxis Therapeutics Revenue and Financials
- Kinoxis Therapeutics Highlights
- Kinoxis Therapeutics Business Model
- Kinoxis Therapeutics Risk Factors
- Kinoxis Therapeutics Research Report from SACRA Research
Trading Kinoxis Therapeutics Stock
How to invest in Kinoxis Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Kinoxis Therapeutics through EquityZen funds. These investments are made available by existing Kinoxis Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Kinoxis Therapeutics stock?
Shareholders can sell their Kinoxis Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
